LINC02166 and breast cancer: Although LINC01614, LINC01615, LINC02166, and LMNTD2-AS1 were all overexpressed in BC tissues (Supplementary Figure S1A–H), only overexpression of LINC01614 predicted a poor prognosis for BC patients (Figure 9A,B).